Mizuho Raises Inspire Medical Systems (NYSE:INSP) Price Target to $250.00

Inspire Medical Systems (NYSE:INSPFree Report) had its target price lifted by Mizuho from $225.00 to $250.00 in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a buy rating on the stock.

Other equities research analysts also recently issued research reports about the company. TheStreet downgraded Inspire Medical Systems from a c- rating to a d+ rating in a report on Thursday, October 26th. JPMorgan Chase & Co. lowered their price objective on shares of Inspire Medical Systems from $340.00 to $181.00 and set an overweight rating for the company in a research note on Tuesday, October 17th. Leerink Partnrs reissued a market perform rating on shares of Inspire Medical Systems in a research report on Monday, October 16th. SVB Leerink began coverage on Inspire Medical Systems in a research report on Monday, October 16th. They set a market perform rating and a $159.00 price target for the company. Finally, Wells Fargo & Company lowered Inspire Medical Systems from an overweight rating to an equal weight rating and cut their price objective for the company from $245.00 to $187.00 in a report on Wednesday, December 13th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. According to MarketBeat.com, Inspire Medical Systems has a consensus rating of Moderate Buy and a consensus price target of $272.92.

Read Our Latest Research Report on INSP

Inspire Medical Systems Price Performance

Shares of NYSE:INSP opened at $202.16 on Wednesday. The firm has a 50 day moving average of $190.38 and a 200 day moving average of $194.45. Inspire Medical Systems has a 52 week low of $123.27 and a 52 week high of $330.00.

Inspire Medical Systems (NYSE:INSPGet Free Report) last issued its quarterly earnings data on Tuesday, February 6th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.53. The firm had revenue of $192.51 million for the quarter, compared to the consensus estimate of $186.75 million. Inspire Medical Systems had a negative net margin of 3.39% and a negative return on equity of 4.02%. The company’s quarterly revenue was up 39.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.10 EPS. Equities research analysts predict that Inspire Medical Systems will post -0.77 EPS for the current year.

Hedge Funds Weigh In On Inspire Medical Systems

Several institutional investors and hedge funds have recently bought and sold shares of INSP. Swiss National Bank boosted its position in shares of Inspire Medical Systems by 1.9% during the 2nd quarter. Swiss National Bank now owns 63,500 shares of the company’s stock worth $20,615,000 after acquiring an additional 1,200 shares in the last quarter. SG Americas Securities LLC acquired a new stake in shares of Inspire Medical Systems during the third quarter worth about $1,452,000. Cetera Advisor Networks LLC boosted its stake in shares of Inspire Medical Systems by 18.6% during the second quarter. Cetera Advisor Networks LLC now owns 1,124 shares of the company’s stock worth $365,000 after buying an additional 176 shares during the period. Qsemble Capital Management LP purchased a new position in shares of Inspire Medical Systems during the third quarter worth about $823,000. Finally, Beacon Investment Advisory Services Inc. increased its position in Inspire Medical Systems by 1,177.2% in the 3rd quarter. Beacon Investment Advisory Services Inc. now owns 9,145 shares of the company’s stock valued at $1,815,000 after acquiring an additional 8,429 shares during the period. 94.91% of the stock is currently owned by institutional investors and hedge funds.

About Inspire Medical Systems

(Get Free Report)

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

Further Reading

Analyst Recommendations for Inspire Medical Systems (NYSE:INSP)

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.